Related to Biopharma Venture Funds Are Stepping Up Where VC Firms Are Stepping Out

• NY Biotech Leaders Pursue Empire State of Mind with One-Stop Shop Proposal
  Think tank is also promoting tax credit extensions, tailored incentives, and easier tech transfer as cures for state’s life science blues.
  
• More VC But Fewer Deals Signal That Investors Are Becoming Even More Risk Averse
  While the love affair may be ending, venture capitalists are still opening up their wallets to later-stage companies.
  
• What Does It Take to Swing the IPO Window Open for Biotechs?
  Suggestions include selling at a discount at a time when there is a rising investor fan-base for social media.
  
• Continuing Freeze in Credit Warms Biopharma to Royalty Monetization Deals
  Industry and academia are both turning to this type of financing for cash now.
  
• Private Exchanges Emerge as an Alternative Financing Strategy
  Firms can stay private but trade their shares on these exchanges.
  
• Biopharma Will Need More than New Law to Embrace Crowdfunding
  Since product development takes longer and industry has more regulation, financing alternative has yet to prove itself.
  
• Even If Bills to Hasten Drug Approvals Pass, Investments May Remain Dry Longer than Stakeholders Claim
  Accelerated approval of any form will likely not sufficiently irrigate the valley of death.
  
• Buyout Options Gaining a Foothold in Deals Means that More than the Price Is Right
  Buyout rights are attractive to smaller firms as they offer up-front payments and a longer-term path to liquidity.
  
• Recent Flurry of New Life Science Funds Aim to Start Bridging the Valley of Death
  It remains to be seen whether these partnerships will succeed in advancing more medicines.
  
• M&A Likely to Continue Growing Along with Deal Premiums and Multiples
  Slow comeback of IPO market will keep companies looking for opportunities to be acquired.
  
• Biopharma Job Outlook Bleak through Mid-Decade
  Restructuring, outsourcing, and patent expirations have combined to create a tumultuous job market.
  
• NIH Taps 25 Schools to Receive Top Dollars
  Did your alma mater make the list?
  
• Top 25 Biotech Companies
  Did your company make the list?
  
• Top 10 Pharma Firms
  Check out which companies made the list.
  
• Top 20 Pharma-Friendly Congress Members
  Who accepted the biggest pharmaceutical company contributions? Find out here.
  
• Top 15 CEO Salaries: Biotech Tool Providers
  Find out who's raking in the most in life science gadgetry.
  
• Candidates’ Science Answers Raise More Questions
  Presidental candidates’ responses to ScienceDebate.org query are inadequate and more discussion is essential.
  
• Virtual Companies’ Benefits, and Costs, All Too Real
  VCs are attracting Big Pharma’s attention, but data validation remains a problem.
  
• Top 20 Molecular Millionaires
  Which biopharma company leaders are raking in the most in shares?
  
• Top 10 Best-Selling Drugs of the 21st Century
  Find out which drugs are in the most medicine cabinets.